Sarah Bechta, a wife, mother and physician from Northborough, Mass. sat down at her kitchen table with a folder full of brochures, pages from insurance websites and a hand-drawn spreadsheet to try to find out if a new "tiered" health plan would be the cheapest option for her family.
She started by comparing her premium for traditional insurance and a tiered plan. Tiered insurance is being offered by various companies in Massachusetts as a way to meet employers’ demands for cheaper insurance premiums.
A tiered plan would cut Bechta’s premium in half and "would save about $1,400 a year. It made me stop and think," she said.
But would she actually save that $1,400 or would it be eaten up in higher co-payments and deductibles?
"That was the thing that was really hard to predict. I could not figure it out," Bechta said, even though, as a doctor, Bechta believes that she's "as capable, or more capable, than everybody else who's looking at this information."
Read the full story at: http://tinyurl.com/6pa9grn
Sources: WBUR, NPR, Kaiser Health News
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More